Carisma Therapeutics is a clinical stage biopharmaceutical company developing immunotherapies to treat solid tumors. The company's technology leverages advances in macrophage biology, chimeric antigen receptor engineering and adoptive cellular therapy for the treatment of human disease. Carisma Therapeutics is founded in 2016, with headquarters located at Philadelphia, Pennsylvania.